05.04.2024 15:46:18 - dpa-AFX: *FDA APPROVES BRISTOL MYERS AND 2SEVENTY BIO'S ABECMA FOR TRIPLE-CLASS EXPOSED R/R MULTIPLE MYELOMA

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
BRISTOL-MYERS SQUIBBDL-10 850501 Frankfurt 39,450 25.06.24 20:28:59 +0,075 +0,19% 0,000 0,000 39,290 39,450

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH